Goldenwell Biotech, Inc. SEC filings GWLL

Goldenwell Biotech, Inc. has 85 filings in SEC EDGAR's recent list, going back to Feb 21, 2020. Its latest annual report, Form 10-K, was filed on Jul 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 9, 2026 (officer or director change). The company's fiscal year ends on December 31.

Goldenwell Biotech, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13D Ownership over 5% (active) Oct 9, 2026 —
3 Initial insider ownership Oct 9, 2026 Oct 8, 2026
SC 13G Ownership over 5% (passive) Oct 10, 2023 —
144 Notice of proposed sale Aug 22, 2023 —
SC 13D Ownership over 5% (active) May 23, 2023 —
SC 13D Ownership over 5% (active) May 23, 2023 —
3 Initial insider ownership May 23, 2023 Apr 30, 2021
3 Initial insider ownership May 23, 2023 Apr 30, 2021
SC 13D Ownership over 5% (active) May 23, 2023 —
3 Initial insider ownership May 23, 2023 Apr 30, 2021

Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Food and Kindred Products (SIC 2000)
Listed as
GWLL (OTC)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Solon, OH
SEC filer status
, Emerging growth company
SEC CIK
1800373

Other Food and Kindred Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.